Specific depressive symptoms predict remission to aripiprazole augmentation in late-life treatment resistant depression.

about

Specific depressive symptoms predict remission to aripiprazole augmentation in late-life treatment resistant depression.

Item

http://www.wikidata.org/entity/Q47606871

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Specific depressive symptoms p ...... reatment resistant depression.

@en

Specific depressive symptoms p ...... reatment resistant depression.

@nl

type

Item

label

Specific depressive symptoms p ...... reatment resistant depression.

@en

Specific depressive symptoms p ...... reatment resistant depression.

@nl

prefLabel

Specific depressive symptoms p ...... reatment resistant depression.

@en

Specific depressive symptoms p ...... reatment resistant depression.

@nl

P1476

Specific depressive symptoms p ...... reatment resistant depression.

@en

P2093

Benoit H Mulsant

http://www.w3.org/2001/XMLSchema#string

Daniel M Blumberger

http://www.w3.org/2001/XMLSchema#string

Elizabeth A DiNapoli

http://www.w3.org/2001/XMLSchema#string

Eric J Lenze

http://www.w3.org/2001/XMLSchema#string

John Kasckow

http://www.w3.org/2001/XMLSchema#string

Jordan F Karp

http://www.w3.org/2001/XMLSchema#string

Marie Anne Gebara

http://www.w3.org/2001/XMLSchema#string

P2860

A new depression scale designed to be sensitive to change

Pathways linking late-life depression to persistent cognitive impairment and dementia.

A systematic approach to pharmacotherapy for geriatric major depression

Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications.

Incomplete response in late-life depression: getting to remission

Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.

Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.

Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care.

P304

e330-e335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GPS.4813

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Charles F Reynolds

P577

2017-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28975710

http://www.w3.org/2001/XMLSchema#string

P932

5773368

http://www.w3.org/2001/XMLSchema#string